Healthtech Growth Investors & VC Firms
1213 firms in this list, with a median first check of $1.1M. 281 of them lead rounds. Generated from verified public data and updated continuously.
Detong Capital
ShanghaiSeed–Late Stage$20M
11 people
Boundary Capital
NorthamptonPre-Seed–Growth$190.5K – $635K
4 people
Business Growth Fund
LondonSeed–Growth$3.8M – $38M
9 people
GR Capital
LondonSeries A–Growth$3.2M – $10.8M
6 people
Think.Health
BerlinSeed–Growth$550K – $11M
3 people
Vistara Growth
VancouverGrowth–Late Stage
15 people
Gimv
The HagueGrowth–Late Stage$21M – $430M
11 people
MVM Life Science Partners
LondonSeed–Late Stage$20M – $100M
11 people
Timon Capital
LagosSeed–Growth$100K – $250K
2 people
ISA Ventures
Cedar RapidsPre-Seed–Late Stage$25K – $1M
1 person
Elysian Park Ventures
Los AngelesSeed–Growth$500K – $100M
10 people
V8 Capital Partners
LagosSeed–Growth
13 people
AgeTech Capital
TorontoPre-Seed–Growth
15 people
Asia Africa Investment & Consulting (AAIC)
TokyoGrowth
12 people
Development Bank of Southern Africa
MidrandGrowth
15 people
Egypt Ventures
CairoSeed–Growth
15 people
Founders Future
ParisPre-Seed–Growth
15 people
Kenya Development Corporation
NairobiGrowth
15 people
Predictive VC
New YorkSeed–Growth
6 people
Veritas Capital
New YorkGrowth–Late Stage
Viola Credit
LondonPre-Seed–Late Stage$2M – $50M
12 people
Polaris Capital Group
TokyoGrowth–Late Stage
Shepherd Ventures
San DiegoSeries A–Late Stage$750K – $3M
6 people
Calera Capital
San FranciscoGrowth$50M – $250M
11 people
Related lists
Growth Investors & VC Firms (4757)Healthtech Investors & VC Firms (3208)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Growth Investors & VC Firms in United States (1502)Growth Investors & VC Firms in Global (1414)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Enterprise Software Growth Investors & VC Firms (1186)
Data sourced from public filings and firms' own websites — see our methodology.






































































